27 APRIL 2022
IP transactions in life sciences in ASEAN countries: data exclusivity
While the respective IP laws of ASEAN states differ with regard to data exclusivity in the field of life sciences, all are focused on strengthening the enforcement of IP rights for pharmaceutical products.
Authors:
Vivian Wei Cheng
20 APRIL 2022
IP transactions in life sciences in ASEAN countries: IP ownership and sharing
The respective IP laws of ASEAN states differ when it comes to IP ownership and sharing provisions.
Authors:
Vivian Wei Cheng
13 APRIL 2022
IP transactions in life sciences in ASEAN countries: data export controls
While there are no blanket restrictions on transferring life sciences data outside of ASEAN countries, this must be carried out in compliance with all applicable data protection law or guidelines.
Authors:
Vivian Wei Cheng
23 MARCH 2022
IP transactions in life sciences: data transfer, sharing and exclusivity in China and Canada
It is imperative that life sciences professionals take account of issues surrounding data handling and technology transfer, in order to effectively maintain and enforce their IP rights
Authors:
Anita Nador,
Le Rong,
Nelson Tian,
Jayde Wood and
Wendy Wagner
09 MARCH 2022
Why technology transfer leads to innovation success
Technology transfer is essential to securing favourable outcomes for early-stage inventions. A whistlestop tour of its background and development reveals how crucial it is to enabling organisations to guarantee a return on their research investments
Authors:
Tamara El-Shibib
02 MARCH 2022
Scaling and commercialising strategies: key forms of agreement
WLG professionals from Canada, China and the United Kingdom provide practical guidance on the necessity of seeking local advice when making agreements to commercialise intellectual property
Authors:
Paul Armitage,
Vivian Desmonts and
Mathilda Davidson
23 FEBRUARY 2022
To sell or to license: how to choose the right strategy to commercialise technology rights
There are a number of issues to consider when transferring rights in a technology to another entity. Whether a company opts to sell or license, awareness of the local rules in which the transfer will take place is vital
Authors:
Timothy C. Bailey
26 JANUARY 2022
Licensing considerations for global companies in China
Parties intending to sign licensing agreements in China should be aware of issues that can create obstacles during this process. While licensing can successfully prevent patent infringement claims, both licensor and licensee should be confident about the terms of the agreement.
Authors:
Daniela Shaw,
Le Rong and
Sophia Liu
12 JANUARY 2022
Enforcement-related considerations for patent valuation: the perspective from Canada
The valuation of patent rights is not a straightforward matter. In Canada, the remedies available to patent owners are arguably the most important factor in determining value.
Authors:
Michael Crichton
15 DECEMBER 2021
Crucial clauses in global IP transactions and the importance of local law advice
In this Q&A, three Gowlings WLG professionals provide practical advice from a local law perspective for IP transactions in three jurisdictions: Canada, China and the United Kingdom.
Authors:
Paul Armitage,
Vivian Desmonts and
Mathilda Davidson
